JPMorgan Chase & Co’s TRACON Pharmaceuticals, Inc. Common Stock TCON Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-1
| Closed | -$4 | – | 6801 |
|
|
2023
Q3 | $4 | Buy |
+1
| New | +$4 | ﹤0.01% | 6425 |
|
|
2021
Q4 | – | Sell |
-11
| Closed | -$1K | – | 5977 |
|
|
2021
Q3 | $1K | Sell |
11
-438
| -98% | -$39.8K | ﹤0.01% | 5467 |
|
|
2021
Q2 | $58K | Buy |
449
+353
| +368% | +$45.6K | ﹤0.01% | 4906 |
|
|
2021
Q1 | $16K | Buy |
+96
| New | +$16K | ﹤0.01% | 4978 |
|
|
2020
Q2 | – | Sell |
-1,704
| Closed | -$57K | – | 5008 |
|
|
2020
Q1 | $57K | Buy |
+1,704
| New | +$57K | ﹤0.01% | 4104 |
|
|
2018
Q4 | – | Sell |
-518
| Closed | -$212K | – | 5012 |
|
|
2018
Q3 | $212K | Sell |
518
-42
| -8% | -$17.2K | ﹤0.01% | 3854 |
|
|
2018
Q2 | $302K | Buy |
560
+360
| +180% | +$194K | ﹤0.01% | 3660 |
|
|
2018
Q1 | $92K | Buy |
200
+150
| +300% | +$69K | ﹤0.01% | 3956 |
|
|
2017
Q4 | $34K | Buy |
50
+36
| +257% | +$24.5K | ﹤0.01% | 4254 |
|
|
2017
Q3 | $9K | Buy |
+14
| New | +$9K | ﹤0.01% | 4069 |
|